Tr1x

Tr1X è all'avanguardia in una categoria rivoluzionaria di prodotti basati sulle cellule T regolatrici, volti a curare malattie autoimmuni e infiammatorie, con il potenziale di migliorare significativamente la vita dei pazienti.

Paese

USA

Sito web

tr1x.bio

Fondato

2018

Social

Fonte delle informazioni:

www.tr1x.bio/

Aggiungi alla mia lista

Dirigenti chiave

Bill Lis

Chief Executive Officer

Maria Grazia Roncarolo, MD

Co-founder, President and Head of R&D

David de Vries, MPhil

Co-founder, Chief Operating Officer

Settori

Med Tech

Aggiungi la tua azienda

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.